Publications by authors named "Simi Ahmed"

Claim this Profile
E
Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Esther Latres, Carla J Greenbaum, Maria L Oyaski, Colin M Dayan, Helen M Colhoun, Simi T Ahmed

Diabetes· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.
Peter N Taylor, Kimberly S Collins, Anna Lam, Stephen R Karpen, Brianna Greeno, Simi T Ahmed

Lancet Diabetes Endocrinol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes.
Michaela Waibel, John M Wentworth, Michelle So, Jennifer J Couper, Fergus J Cameron, Simi Ahmed

N Engl J Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum. Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes. Diabetes Care 2022;45:2189-2201.
Randy L Anderson, Linda A DiMeglio, Adrian P Mander, Colin M Dayan, Peter S Linsley, Simi T Ahmed

Diabetes Care· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes.
Randy L Anderson, Linda A DiMeglio, Adrian P Mander, Colin M Dayan, Peter S Linsley, Simi T Ahmed

Diabetes Care· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes.
Ranjeny Thomas, José M Carballido, Johnna D Wesley, Simi T Ahmed

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes.
Andrea K Steck, Xiang Liu, Jeffrey P Krischer, Michael J Haller, Riitta Veijola, Simi Ahmed

J Clin Endocrinol Metab· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.
Manuela Battaglia, Simi Ahmed, Mark S Anderson, Mark A Atkinson, Dorothy Becker

Diabetes Care· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent Advances.
Simi Ahmed, Karen Cerosaletti, Eddie James, S Alice Long, Stuart Mannering

Diabetes· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?
Laura B Smith, Xiang Liu, Suzanne Bennett Johnson, Roy Tamura, Helena Elding Larsson, Simi Ahmed

Pediatr Diabetes· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
Andrea K Steck, Helena Elding Larsson, Xiang Liu, Riitta Veijola, Jorma Toppari, Simi Ahmed

Pediatr Diabetes· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.
Simi T Ahmed, James E Darnell

Biochem Biophys Res Commun· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
Marjan Berishaj, Sizhi Paul Gao, Simi Ahmed, Kenneth Leslie, Hikmat Al-Ahmadie

Breast Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of IL-6 signaling by a p38-dependent pathway occurs in the absence of new protein synthesis.
Simi T Ahmed, Alexander Mayer, Jong-Dae Ji, Lionel B Ivashkiv

J Leukoc Biol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis